Salvage treatment of multi-refractory primary immune thrombocytopenia with CD19 CAR T cells
Salvage treatment of multi-refractory primary immune thrombocytopenia with CD19 CAR T cells
About this item
Full title
Author / Creator
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
The annualised incidence of primary immune thrombocytopenia is approximately 3·3 cases per 100 000 people among adults. 1 Despite several treatment options, including approved thrombopoietin receptor agonists and commonly used antibody-reducing approaches—such as B-cell depletion with the anti-CD20 monoclonal antibody rituximab, BTK inhibitors, SYK...
Alternative Titles
Full title
Salvage treatment of multi-refractory primary immune thrombocytopenia with CD19 CAR T cells
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_3151584217
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3151584217
Other Identifiers
ISSN
0140-6736,1474-547X
E-ISSN
1474-547X
DOI
10.1016/S0140-6736(24)02504-2
